Anti-B7-H3(vobramitamab biosimilar) mAb

Price: 50 μg ￥800.00 ; 100 μg ￥1500.00

SKU: BME100730 Category: Biosimilar reference antibodies

Uniprot ID	Q5ZPR3
Common Name	MGA017;MGA-017;MGA17;MGA-17;MGA 017;MGA 17;MGA018;MGA-018;MGA18;MGA-18;MGA 018;MGA 18;AEX4089;AEX-4089;AEX 4089
Synonyms	B7H3;B7-H3;B7RP-2;4Ig-B7-H3;CD276
Applications	N/A
Recommended Dilutions	N/A
Formulation & Reconstitution	Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Host Species	N/A
IgG type	IgG1
Reactivity	Human
Target	B7-H3
Description	Anti-B7-H3(vobramitamab biosimilar，IgG1) mAb
Delivery	3-4 weeks
Storage & Shipping	Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only；All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.
Conjugate	Unconjugated